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ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2005.07.053Background: Survival after stage I palliation for hypoplastic left heart syndrome or
related anomalies remains poor in high-risk neonates. We hypothesized that a less
invasive hybrid approach would be beneficial in this patient population.
Methods: The hybrid stage I procedure was performed in the catheterization labo-
ratory. Via a median sternotomy, both branch pulmonary arteries were banded, and
a ductal stent was delivered via a main pulmonary artery puncture and positioned
under fluoroscopic guidance.
Results: Between October 2003 and June 2005, 14 high-risk neonates underwent a
hybrid stage I procedure. Eleven of 14 had hypoplastic left heart syndrome. Two
also underwent peratrial atrial septal stenting, and 5 required percutaneous atrial
stenting later. Two neonates with an intact or highly restrictive atrial septum had
emergency percutaneous atrial stent placement. Hospital survival was 11 (78.5%) of
14. One patient required extracorporeal membrane oxygenation support for intra-
operative cardiac arrest. He underwent cardiac transplantation but died later of
sepsis. One patient died of ductal stent embolization, and a third died of progressive
cardiac dysfunction. The first 4 patients required pulmonary artery band revisions.
There were none after we modified our technique and added branch pulmonary
artery angiograms. There were 2 interstage deaths from atrial stent occlusion and
from preductal retrograde coarctation. Eight patients underwent stage II procedures,
consisting of aortic arch reconstruction, atrial septectomy, and cavopulmonary
shunt. Two patients died after stage II. One patient is awaiting stage II.
Conclusions: The hybrid stage I palliation is a valid option in high-risk neonates. As
experience is accrued, it may become the preferred alternative. However, in aortic
atresia, the development of preductal retrograde coarctation is a significant problem.
Despite undeniable recent improvements in survival,1-5 the Norwood stage Ioperation for hypoplastic left heart syndrome (HLHS) and related anoma-lies remains a high-risk endeavor. Even a perfectly executed operation
requires prolonged cardiopulmonary bypass (CPB) with occasional deep hypother-
mic circulatory arrest, multiple blood transfusions, and delayed sternal closure.
Prolonged neonatal CPB, hospitalization, or both, especially in the setting of
hypoxemia and low diastolic pressures, has been linked to poor neurologic devel-
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Dopment.6-8 Risk factors include presentation with shock,
birth weight less than 2.5 kg, prematurity (34 weeks’
gestational age), less than a 2-mm ascending aorta, poor
ventricular function, tricuspid regurgitation, intact or re-
strictive atrial septum, additional cardiac anomalies, or se-
rious noncardiac genetic malformations.1,3,5,9,10 Although
the significance of some of the listed risk factors can be
argued with modern management, high-risk neonates un-
dergoing a stage I Norwood operation still face a mortality
of 20% to 50%.3,5 Thus, a less invasive method of stage I
palliation that effectively palliates symptoms while delaying
the surgical reconstruction until some of the risk factors are
sorted out should be advantageous.
Branch pulmonary artery (PA) banding is one of the
earliest methods of stabilization in HLHS11 and remains
popular today in dire situations12,13 or as pretransplantation
stabilization.14 Encouraged by the initial success of ductal
stenting, some groups15,16 began using percutaneous ductal
stenting followed by surgical band placement for initial
palliation of HLHS. The approach was then modified by
performing ductal stenting via a sternotomy and PA punc-
ture, thus avoiding the issues of percutaneous access, ar-
rhythmias, and valvular regurgitation associated with per-
cutaneous procedures.17 Ultimately, this strategy could
potentially lead to a percutaneous Fontan completion,18
with 1 major on-pump reconstruction sandwiched between
2 interventional procedures. This article reviews our initial
experience with this strategy and highlights potential advan-
tages and shortcomings.
Materials and Methods
The study was performed at The University of Chicago Comer
Children’s Hospital and was approved by the institutional review
board. Informed consent was obtained, and all procedures were
conducted in accordance with institutional guidelines. A prospec-
tive database was maintained, and recently, all patient records
were reviewed. The most recent follow-up data were obtained
from the last outpatient visit. All genetic syndromes were diag-
nosed by a pediatric geneticist.
The procedure is performed in the catheterization laboratory,
which is prepared by having the surgical nursing team set up
instruments as if in the actual operating room. A transesophageal
echocardiography probe is placed if the atrial septum is to be
approached. Under usual monitoring, the chest, abdomen, and
groin are prepared and draped. A median sternotomy is performed.
The chest retractor is placed in such a way as to be able to be
Abbreviations and Acronyms
CPB  cardiopulmonary bypass
HLHS hypoplastic left heart syndrome
PA  pulmonary artery
PTFE  polytetrafluoroethyleneremoved when fluoroscopy is performed. Rings 1.5 mm wide are
164 The Journal of Thoracic and Cardiovascular Surgery ● Janucut off a standard 3.5-mm polytetrafluoroentylene (PTFE) tube
graft (Gore-Tex tube graft; W. L. Gore & Associates, Inc, Flag-
staff, Ariz) and cut open. A 5-0 polypropylene mattress suture is
placed through one end of the cut ring. The right PA is encircled
to the right of the ascending aorta, and the PTFE band is pulled
through by using the arms of the 5-0 suture. The suture is then
passed through the other end of the band and tied. A clip is placed
over the sutured portion, and further clips can be used to tighten
further, if necessary. The left PA is similarly banded at its origin.
It is important to avoid dissecting the branch PAs more than
necessary so the surrounding tissues can be used as protection
against band migration. Because of 1 instance of distal band
migration (patient 12), we now use extra sutures fixing the band to
surrounding tissues to prevent this significant problem.
Next, a 5-0 polypropylene purse-string suture is placed at the
sinotubular junction of the main PA. Heparin 50 IU/kg is given.
The main PA is punctured with a 21-gauge needle (Cook Inc,
Bloomington, Ind), and a 0.018-inch short guidewire is passed into
the descending aorta via the ductus. A short 6F sheath is then
advanced over the guidewire, positioned with the tip inside the
vessel by 2 to 3 mm only, and secured as if an aortic cannula would
be secured. An angiogram is performed by using the sheath in the
main PA in a 45° left anterior oblique angulation to profile the
aortic arch and ascending aorta, measure the ductal diameter, and
assess the position and appropriateness of the bands (Figure 1).
Figure 1. Initial angiogram obtained after branch PA banding
(patient 13). The left pulmonary artery band is seen (thick black
arrow). The isthmus is widely patent in this case (white arrow).
An atrial stent is seen (placed urgently for restrictive atrial
septum). The right atrial appendage also contains a purse-string
suture with a tourniquet (thin black arrow) through which an
atrial line was passed. The main pulmonary artery sheath is
depicted with a thick black arrow.The proper size of self-expandable stent (usually 7 or 8  20 mm)
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Dis then advanced over the guidewire. The stent is placed so that the
distal end of it is just protruding into the descending aorta and the
proximal part is just above the branch PA openings. We have been
using either the Precise (Cordis, Johnson & Johnson, Warren, NJ)
or Protégé (ev3 Inc, Plymouth, Minn) stents. Once the stent is
deployed, a repeat angiogram is performed to assess the position of
the stent, the PA bands, and the aortic arch. If the stent is not
covering the entire ductus, another stent is deployed to overlap the
first stent (1 case in our experience). If the PA bands are deemed
to be too tight or too loose, they can be adjusted accordingly. In
addition to using the arterial saturation or blood pressure as a guide
for band diameter, we aim for a diameter of the banded portion of
the PA to be approximately 30% to 40% of the diameter of the
proximal PA. If the bands cannot be profiled adequately, we have
inserted a Judkins Right catheter into the sheath and performed
selective branch PA angiograms (Figure 2). If the atrial septum is
restrictive, then the atrial communication can be enlarged by using
a self-expandable stent placed via a peratrial approach under
transesophageal echocardiography guidance. An intracardiac com-
mon atrial monitoring line is always placed before chest closure.
Results
Between November 2003 and June 2005, we performed 14
hybrid stage I procedures, consisting of single-stage ductal
stenting and bilateral branch PA banding (Table 1). Eleven
patients (78.5%) had HLHS. The median weight was 2.8 kg
(range, 2.2-3.3 kg), and the median age was 5.7 days (range,
Figure 2. A Judkins Right catheter (thin black arrow) is passed
through the main PA sheath (white arrow) and positioned over a
flexible wire in the right PA for selective angiography (patient 12).
The band is too loose. The tourniquet holding the sheath is shown
by a thick black arrow.1-17 days). Preoperative risk factors were present in all
The Journal of Thoracipatients and included aortic atresia in 8, severe noncardiac
genetic anomaly and weight less than 2.5 kg in 4, poor
ventricular function in 3, intact or highly restrictive atrial
septum and additional cardiac defect in 2, and prematurity
(34 weeks’ gestational age), intracerebral bleed, presen-
tation in shock, left ventricular coronary fistulas, partial left
diaphragmatic hernia, and necrotizing enterocolitis in 1
each. All patients were intubated before surgery. All pa-
tients but one had their chests closed primarily. Two re-
quired an intraoperative increase or initiation of inotropic sup-
port. Operation (“skin-skin”) time was 100  37 minutes.
Hospital survival after hybrid stage I procedures was 11
(78.5%) of 14 patients. There were 3 in-hospital deaths: 1
patient (no. 2) had a cardiac arrest during passage of the
wire into the descending aorta. He required emergency
extracorporeal membrane oxygenation support and subse-
quently required heart transplantation. He died of sepsis at
8 weeks of age. We speculate that a coronary clot caused the
arrest, although inspection of the explanted heart failed to
conclusively settle the question. Another death occurred on
the day before hospital discharge because of stent dislodg-
ment into the descending aorta with subsequent ductal con-
striction and death (patient 9). The third in-hospital death
occurred in a severely dysmorphic patient (no. 12) with
severe preoperative ventricular dysfunction and tricuspid
regurgitation, who, on the basis of her genetic dysmor-
phism, was deemed not to be a candidate for extracorporeal
membrane oxygenation. The procedure was uneventful
(Figure 3), but her cardiac output continued to deteriorate,
and she had a cardiac arrest 6 hours after the operation.
There were 2 interstage fatalities: 1 patient (no. 4) died
immediately before his scheduled stage II procedure of
atrial stent migration and subsequent atrial septal restriction
(Figures E1 and E2). Another patient (no. 10) with HLHS
and an intact atrial septum was discharged from the hospital
19 days after successful percutaneous atrial stenting fol-
lowed by a hybrid stage I procedure. He died suddenly 8
days after discharge. Autopsy showed a 2-mm opening into
the transverse arch with ductal tissue surrounding that
opening.
Survival to stage II was 8 (61%) of 13. Eight patients
underwent a stage II reconstruction consisting of stent re-
moval, aortic arch reconstruction, and cavopulmonary shunt
in 7 and conversion to biventricular repair in 1. One patient
(no. 7) had a 3-mm opening into his arch diagnosed during
angiography (Figure 4). Six patients survived. One died
from superior vena cava thrombosis related to heparin-
induced thrombocytopenia, and 1 died from low cardiac
output. One other patient later died at home at age 8 months
from a sudden infection likely related to severe T-cell
malfunction related to DiGeorge syndrome. One patient is
currently awaiting a stage II operation.
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DThe atrial septum was initially deemed nonrestrictive
in 10 of 14 patients. Two patients underwent peratrial
deployment of an atrial septal stent via a direct puncture
of the right atrial free wall during hybrid stage I. Another
2 patients had an intact or near-intact atrial septum and
underwent emergency percutaneous placement of an
atrial stent right after birth. Four of the 10 who were
initially deemed nonrestrictive required percutaneous
atrial stenting at 1, 1.5, 2, and 3 months after surgery.
Two patients had atrial stent migration; 1 died at home,
and the other required open surgical septostomy.
One patient required repeat percutaneous stenting be-
cause of distal migration of the ductal stent. Bands had to be
tightened via resternotomy in the first 4 patients. Two pa-
tients required left PA stenting shortly after stage II.
Our current protocol is to proceed with the hybrid stage
TABLE 1. Clinical experience with 14 consecutive hybrid
Patient no. Diagnosis
Age (d)/weight
(kg) Risk facto
1 HLHS (AS, MS) 5/2.9 Very poor ventricu
moderate TR
2 HLHS (AA, MS) 1/3.2 AA, severe LVH
3 IAA(C), CAVC,
BSVC
9/2.6 CHARGE syndrome
4 HLHS (AA,MA),
L-TGA
17/3.3 AA, NEC (intestina
pneumatosis)
5 HLHS (AA, MA) 3/3.1 AA, congenital
tracheomalacia
6 IAA(C), AS,
subAS, VSD
4/2.7 Confirmed T-cell d
(DiGeorge), cong
partial left diaph
hernia
7 HLHS (AA, MA) 6/2.2 AA, weight, 32 wk
age, LV-coronar
8 HLHS (AA, MA) 1/3.2 AA
9 IAA(B)/CAVC 5/2.4 Weight
10 HLHS (AA, MA) 7/3 AA, intact atrial se
11 HLHS (AA,
MS), BSCV
5/2.5 Cerebral bleed, AA
CHARGE syndro
12 HLHS (AA,
MA), PAPVR,
dextrocardia
7/2.7 Severe ventricular
dysfunction, mod
nondescript gen
syndrome
13 HLHS (AA, MS) 4/3.2 Highly restrictive a
14 HLHS (AA, MS) 3/2.4 AA, weight, intesti
malrotationI procedure early after birth. Postoperative management is
166 The Journal of Thoracic and Cardiovascular Surgery ● Januroutine. We perform echocardiograms at least weekly, even
after discharge. At 6 weeks, consideration is given to a
cardiac catheterization to check the position of the stent(s)
and bands (Figure E3). If the atrial septum is restrictive, it
is stented or dilated at that time. The stage II procedure is
performed at 12 to 24 weeks of age.
Discussion
The 3 tenets of stage I palliation for HLHS are the estab-
lishment of an unobstructed systemic outflow, a nonrestric-
tive atrial septal defect, and a controlled source of pulmo-
nary blood flow. Coronary blood flow also needs to be
reliable. If the hybrid stage I procedure is to be successful,
it has to ultimately satisfy all of these criteria.
Despite a difficult learning curve, this pilot series of 14
consecutive hybrid stage I palliation procedures demon-
e I procedures (November 2003 to June 2005)
Atrial septum
Intraoperative
complications
nction, Nonrestrictive 2 ductal stents placed to
cover entire duct
Peratrial stent Cardiac arrest
Nonrestrictive No
Nonrestrictive Unable to band LPA
Peratrial stent Arrhythmias
ction
l
atic
Nonrestrictive No
ational
ulas
Nonrestrictive No
Nonrestrictive No
Nonrestrictive No
Percut. RFA  atrial stent No
ck, Nonrestrictive No
e TR,
Nonrestrictive No
septum Percut. atrial stent DOL 1 No
Mildly restrictive Nostag
r(s)
lar fu
l
ysfun
enita
ragm
gest
y fist
ptum
, sho
me
erat
etic
trial
nalstrates that acceptable results can be achieved in a very-
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Dhigh-risk group. No patient was excluded from the study,
and, thus, this report encompasses all the technical or decision-
making errors that were due to our unfamiliarity with this
procedure. With more experience, time, and new technol-
ogy, results should improve.
Obstruction of pulmonary venous return and the presence of
a significant noncardiac malformation or genetic syndrome are
.
Postop course
Interstage
complications
Age (mo
weight (k
at stage
Benign LPA rebanding and percut
atrial stent 3 mo postop
3.5/4.2
ECMO-heart Tx Died of sepsis age 8 wk N/A
Benign Poor feeding (cleft lip/
palate)
5/4.3
LPA band via left
thoracotomy; percut.
atrial stent 5 wk
postop
Died at 5 mo of subacute
occlusion atrial stent
(autopsy)
N/A
Ductal stent migration,
percut 2d ductal
stent, tracheostomy
Atrial septect. for atrial
stent stenosis and LPA
rebanding
4/4.3
Benign No 4/4.2 (Yasu
biventric
repair)
Benign Preductal CoA at pre–
stage II cath
3/4.5
Benign Percutaneous atrial stent
placed 6 wk postop
3/5.5
Died POD 18 (ductal
stent embolization)
N/A N/A 
Benign Sudden death at outside
hospital
N/A
Benign No 4/5.0
Cardiac arrest 6 h
postop (not ECMO
cand.)
N/A N/A
Failed extubation No 3/4.1
Ladd procedure for
malrotation on POD 4
Percutaneous atrial
septostomy
N/A
AA, Aortic atresia; AS, aortic stenosis; BSVC, bilateral superior venae cava
CHARGE syndrome, coloboma, heart defects, atresia of the choanae, reta
abnormalities and/or hearing loss; CoA, coarctation of the aorta; CPS, c
membrane oxygenation; fct, function; F/U, follow-up; IAA(C), interruption of
hypoplastic left heart syndrome; HITT, heparin-induced thrombocytopenia a
hypertrophy; L-TGA, levo-transposition of the great arteries; MA, mitral a
PAPVR, partial anomalous pulmonary venous return; precut 2-d, percuta
performed); RFA, radiofrequency ablation of atrial septum; septect, septe
ventricular septal defect.independent risk factors demonstrated in multivariable analy-
The Journal of Thoracises.3,5,10,19 Mortalities in the range of 50% are reported.3,5,19
Four patients had genetic syndromes, and 2 had severe ob-
struction of pulmonary venous return. Out of this very-high-
risk group of 6 patients (2 also had additional cardiac defects),
5 survived to discharge after hybrid stage I procedures. Al-
though this is a very small group of patients, therein may lie the
most obvious benefit of this procedure. This has also been the
Intraop
complications Postop course
Status/age
at F/U
No Prolonged inotropes
for poor ventr fct
Well/20 mo
N/A N/A Dead
Bleeding Benign Well/19 mo
N/A N/A Dead
Difficult distal
aortic stent
removal
Died from HITT
(thrombosed CPS)
Dead
ECMO  4 d for
malignant
arrhythmias
D/C POD 40 Sudden death at
home/8 mo
LPA reconstruction LPA stent POD 42,
thrombosed LPA
POD 72
Well/13 mo
No LPA stent POD 55 Well/13 mo
N/A N/A Dead
N/A N/A Dead
LPA reconstruction ECMO Dead
N/A N/A Dead
No Moderate TR Well/5 mo
N/A N/A Well, 4 wk,
awaiting stage II
d, candidate; cath, catheterization; CAVC, complete atrioventricular canal;
n of growth and development, genital and urinary abnormalities, and ear
lmonary shunt; D/C, discharged; DOL, day of life; ECMO, extracorporeal
ortic arch (complete); intraop, during surgery; postop, after surgery; HLHS,
rombosis; LPA, left pulmonary artery; LV, left ventricle; LVH, left ventricular
; MS, mitral stenosis; N/A, not applicable; NEC, necrotizing enterocolitis;
2-dimensional; POD, postoperative day (always refers to last operation
y; TR, tricuspid regurgitation; Tx, transplantation; ventr, ventricular; VSD,)/
g)
II
i
ular
e; can
rdatio
avopu
the a
nd th
tresia
neous
ctomfinding of other groups involved in this field.17,20
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DPros and Cons of the Hybrid Stage I
Pros. The main advantages include avoidance of neona-
tal CPB, the possibility of achieving complete palliation
with 2 pump runs instead of 3, and the avoidance of early
neonatal trauma due to prolonged hospitalization. Long-
term neurologic development and IQ after the Norwood
stage I procedure have been historically unsatisfactory, spe-
cifically with the combination of hypoxemia and low dia-
stolic pressure that can be a typical feature of postoperative
care.7 Periventricular leukomalacia has been seen in more
than 50% of neonates after complex repairs, but it is rare in
infants.7
The stage II reconstruction is a very challenging redo
operation, involving stent removal, arch reconstruction, and
cavopulmonary shunting. However, the patient recovers
with circulation in series and not in parallel, as occurs after
the Norwood stage I. Early palliation with circulation in
parallel, as in the Norwood operation, requires that ventric-
ular output must be maintained at a level that is 2 to 3 times
normal.21 Right ventricular function has been shown to be
better after cavopulmonary shunt operations than after volume-
loading procedures.22 Finally, there is evidence that myocar-
dial damage after heart surgery is greater in neonates as
opposed to infants.23,24
Cons. Disadvantages of this procedure include recent
data showing decreased preoperative cerebral blood flow in
neonates with complex congenital heart disease.25 In aortic
Figure 3. An extremely diminutive ascending aorta is shown on
the initial angiogram (white arrow). This patient (patient 12) with
multiple genetic anomalies presented with severe ventricular
dysfunction, which progressed after a hybrid stage I procedure.
Coronary flow may have been impaired.
168 The Journal of Thoracic and Cardiovascular Surgery ● Januatresia, the possibility of coronary malperfusion or cerebral
malperfusion is real if the isthmus or a portion of the
transverse arch becomes stenotic. The ductal stent by ne-
cessity covers the isthmic opening into the transverse arch
because it has to cover the entire duct to prevent ductal
constriction (Figure 5). In aortic atresia patients, we now
specifically image the entire aortic arch and ascending aorta
during the initial angiogram (Figure 1) to exclude any
significant stenoses that, if present, would preclude us from
proceeding with hybrid stage I palliation. However, that
may not be the solution to this problem, because histopatho-
logic studies of HLHS specimens have documented that
ductal tissue often extends in the preductal position, espe-
cially in aortic atresia.26,27 Therefore, at this time, there is
no way to reliably exclude that possibility, because even a
nonstenotic isthmus may become stenotic once prostaglan-
dins are discontinued. This may be the Achilles heel of the
hybrid stage I procedure. Further morphologic research is
needed to describe the frequency of preductal coarctation in
HLHS with aortic atresia, as is improved and more accurate
recognition of this problem before surgery. Technically,
ductal stenting per se was uncomplicated. Because of the 2
instances of distal stent migration, we now routinely mea-
sure the ductal width on initial arch angiogram and oversize
the stent by 1 mm. Another option would be to use balloon-
expandable stents, with which we do not have any experi-
Figure 4. Pre–stage II angiogram at 3 months shows preductal
coarctation. This patient (patient 4) was taken to the operating
room the next day.ence in this setting.
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DBanding the branch PA may lead to stenosis or distor-
tion. However, data from Denver in the pretransplantation
PA-banded population support the notion that PA bands do
not induce prohibitive stenoses.14 Furthermore, aortopulmo-
nary shunts and right ventricle/PA conduits also carry the
possibility of PA distortion. Since adopting the method of
the selective branch PA angiogram (described previously),
we have not had to revise bands in the last 10 patients. We
also now routinely patch the left PA at the time of the stage
II procedure. The right PA has not been a problem because
the vessel has opened nicely (Figure E4) after band removal
and because the superior vena cava is anastomosed directly
over the band site.
A final disadvantage is that a reliable atrial septostomy is
difficult to achieve with the hybrid stage I procedure. Our
experience with atrial stenting in the long term is mixed at
best. As a consequence, we do not rely on atrial stents for
more than 3 months. Patients who have atrial stents are
scheduled for an elective stage II procedure at 3 to 4 months
of age.
Current Indications
On the basis of our current experience, we believe that the
hybrid stage I operation is indicated in neonates with major
noncardiac genetic defects, cerebral hemorrhage, intact or
highly restrictive atrial septa, poor ventricular function, late
presentation, nonresolving end-organ damage from shock at
presentation, and nonresolved sepsis (in unstable patients).
We believe that this operation is contraindicated in neonates
with a possibility of preductal coarctation in aortic atresia or
Figure 5. Ductal stent well embedded after 5 months (patient 7).
The opening into the transverse arch is shown with a probe.neonates with interruption of the aortic arch (danger of
The Journal of Thoraciductal stent embolization). The role of the hybrid stage I
procedure remains unclear in patients with aortic atresia
without evidence of arch stenoses and in low-risk patients
with HLHS or other single-ventricle anomalies, who cur-
rently have improved survival.
The Future
Development of new technologies will undoubtedly im-
prove outcomes and widen the indications of less invasive
hybrid strategies. Absorbable stents for temporary ductal
stenting, improved intraoperative imaging, or ultrasound
tissue erosion28 for percutaneous creation of an unrestrictive
atrial septal defect, as well as percutaneous flow occluders,
could help surmount some of the early problems seen in this
study. Oral prostaglandins in conjunction with branch PA
banding have also been used. This would theoretically cir-
cumvent the problem of retrograde coarctation. Safer tech-
niques for direct cardiac access for delivery of devices
through the unopened chest would render the sternotomy
obsolete.
Conclusion
The hybrid stage I palliation is a valid option in high-risk
neonates. As experience is accrued, it may become the
preferred alternative. However, in aortic atresia, the devel-
opment of preductal retrograde coarctation is a significant
potential problem.
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Discussion
Dr Tom R. Karl (San Francisco, Calif). A hybrid is an organism
that is an offspring of genetically dissimilar parents said to possess
different desirable characteristics, with the premise that the off-
170 The Journal of Thoracic and Cardiovascular Surgery ● Januspring will possess all of them or, to put it another way, where
elements comprising a word are derived from different languages.
I think this is a very apt description of this experience.
The credibility of your work is enhanced by the quality of both
the surgery and interventional cardiology in your unit, which I
think gives you a good advantage for exploring this strategy. The
approach has generated results that are very competitive with
surgical strategies applied in other units, and moreover the patients
have been selected from the most unfavorable end of the hypo-
plastic left heart spectrum. As such, this approach is certainly
deserving of further investigation, especially to test its reproduc-
ibility in other centers, since, as you said, currently there are only
a handful who have reported results for this strategy, either as a
palliation prior to transplant or as a bridge to more definitive stage
II construction.
So I have just a few questions.
The first is, how have you modified your Norwood procedure to
accommodate the presence of this large stent, which has become
very well embedded in the ductus and part of the descending aorta,
prior to your intervention?
Dr Bacha. It’s a new operation and not so much a modification
of the Norwood procedure. It’s a big operation. The ductus is rock
hard, and removing the ductal stent is not straightforward. I usually
don’t use circulatory arrest for the Norwood procedure, but you
end up having to use circulatory arrest often in this procedure, so
there is definitely a trade-off that occurs with a very large stage II
operation but a less invasive stage I.
Dr Karl. And did you experience any of the commonly seen
extracardiac complications from the Norwood operation when you
used this hybrid approach, for example, laryngeal dysfunction,
gastrointestinal complications, and so forth?
Dr Bacha. Yes. As I mentioned yesterday, we found the same
incidence of laryngeal dysphasia as we saw after the Norwood
operation in these patients, prompting us to think that this may be
due to more of a genetic makeup of these patients as opposed to
surgery causing laryngeal dysfunction.
Dr Karl. The third question is, was any specific anticoagula-
tion regimen employed?
Dr Bacha. We give heparin 50 U/kg during the procedure after
banding, at the time when we are passing the wire into the
descending aorta, and those patients are placed on a half a baby
aspirin postoperatively.
Dr Karl. Regarding pulmonary artery growth and development
with this strategy, has this had an effect on the clinical course
following the bidirectional cavopulmonary shunt?
A big concern is that you’re subjecting patients to a bidirec-
tional cavopulmonary shunt under difficult circumstances follow-
ing a long operation, and one would have to have a very good
pulmonary bed to achieve success with this second stage. Has this
been the case, or have you experienced problems in oxygenation?
Dr Bacha. Well, a lot of the stage II’s were done in young
patients, closer to 3 months than 6 months. As we know from the
Milwaukee series, they will come out of the operating room quite
cyanotic and recover over the next days. So generally speaking, I
would say the patients have been bluer than I’m used to after the
standard cavopulmonary shunt. The left pulmonary artery I find
has to be patched at the time of stage II operation, whereas the
right pulmonary artery does not have to be patched and you can
ary 2006
Bacha et al Surgery for Congenital Heart Diseaseimplant the superior vena cava right over the area of the band.
However, the key difference is that you now have a circulation in
series as opposed to in parallel, as after a Norwood operation.
Dr Karl. And the final question is, do you have a feel for how
the results of this strategy compared to results of the standard
Norwood operation for similar patients in your own unit? In other
words, have you actually improved your results by employing this
strategy?
Dr Bacha. Well, it’s tough to compare, because since starting
this strategy we have not done Norwoods on high-risk patients, so
our results have improved somewhat. So overall you would say the
Norwood procedure results have improved from my unit because
we’ve excluded now-high-risk patients.
Dr Glen S. Van Arsdell (Toronto, Ontario, Canada). My partner,
Chris Caldarone, has embarked on this strategy. We have analyzed
V˙O2 data and have found that the pulmonary blood flow is actually
higher and the Qp:Qs is higher than in Norwood patients.
This fact might lead one to assume that there may be some
interval problems that are the same as the Norwood’s because of
the high demands on the myocardium. Has all your interval mor-
tality been explainable by some anatomic problem? Or, as in the
Norwood patients, have you sometimes seen mortality that you
couldn’t explain by an anatomic deficiency?
Dr Bacha. Well, we’ve had 2 interstage deaths. One was
clearly a technical problem with the atrial stent that had migrated.
That was autopsy proven. The other was a little bit unclear, and we
speculate it’s a problem of coronary flow down in the coronaries
with a retrograde coarctation in aortic atresia. Most of the deaths,
I would say, in this series have been more a learning curve issue
and problems with technical aspects of the procedure we have not
mastered quite yet.
Dr Christian Pizarro (Wilmington, Del). Emile, I really en-
joyed your presentation. I have one question about the self-expanding
stent.
I saw that you had migration of the stent in a couple of cases.
Perhaps the fact that it is self-expanding, it is an issue in the sense
The Journal of Thoracithat it’s not as well embedded or secured in place immediately after
deployment. In our experience we have used balloon-expandable
stents, and we had no migration problems. In our practice, the
self-expanding stent has always raised discussion about the possi-
bility of migration, and you’ve clearly shown that that’s a valid
concern. Based on this, are you changing your practice, or what are
your thoughts about this?
Dr Bacha. We’ve used only self-expandable stents. I don’t
have any experience with balloon-expandable stents. What we’ve
changed, following the incidence of ductal stent embolization, is
that we are oversizing the stent by 1 mm. So if we measure a 7-mm
ductus, we’ll go to an 8-mm stent. However, migration has been an
issue with the self-expandable stents with at least 2 patients in our
series.
Dr Frank L. Hanley (Stanford, Calif). I enjoyed the presen-
tation very much.
Given your patient profile, it’s not unrealistic that these patients
are going to stay in the hospital 7, 8, or 9 weeks given their
syndromes, size, and other risk factors. If you put the patients on
prostaglandin E and band them, an idea put forth in the Japanese
literature, you would reduce the complexity of both your first-stage
and your second-stage procedures quite substantially, and since
they’re going to be in the hospital for a long time anyway, the end
result would most likely be very little extra time in hospital
between stages I and II, when all is said and done. What do you
think about that approach?
Dr Bacha. I think that’s a reasonable approach, although I
would not favor it necessarily, because obviously with prostaglan-
din E you have to keep a line in. I guess you could do a periph-
erally inserted central catheter line and so forth.
The goal here is to get the patient out of the hospital if possible
without any lines. Some of the complications that we’ve seen with
ductus stenting, I believe, are more growing pains than problems.
I mean, those are problems that we will be able to overcome, I’m
pretty sure.
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DFigure E1. This patient (patient 4) died before the stage II procedure, at 5 months of age, from occlusion of his atrial
septum. This photograph shows the left atrial side with a probe through the opening.
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Figure E4. The right PA is opened after 5 months of banding (patient 4). No intimal lesions are seen.The Journal of Thoracic and Cardiovascular Surgery ● Volume 131, Number 1 171.e2
